|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
11250161 |
| 006 |
m o d |
| 007 |
cr bnu|||aucuu |
| 008 |
151118s2015 ne o 001 0 eng d |
| 005 |
20241016133411.1 |
| 019 |
|
|
|a 930336711
|
| 020 |
|
|
|a 9780444635310
|q (electronic bk.)
|
| 020 |
|
|
|a 0444635319
|q (electronic bk.)
|
| 020 |
|
|
|z 9780444635259
|
| 020 |
|
|
|z 0444635254
|
| 035 |
|
9 |
|a (OCLCCM-CC)929886684
|
| 035 |
|
|
|a (OCoLC)929886684
|z (OCoLC)930336711
|
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d N$T
|d IDEBK
|d YDXCP
|d OCLCQ
|d DEBBG
|d D6H
|d AU@
|d OPELS
|d OCLCQ
|d OPELS
|d INARC
|d OCLCO
|d OCLCQ
|
| 049 |
|
|
|a MAIN
|
| 050 |
|
4 |
|a RM302.5
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 245 |
0 |
0 |
|a Side effects of drugs annual.
|n Volume 37 :
|b a worldwide yearly survey of new data in adverse drug reactions /
|c edited by Sidhartha D. Ray.
|
| 264 |
|
1 |
|a Amsterdam, Netherlands :
|b Elsevier,
|c 2015.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes indexes.
|
| 588 |
0 |
|
|a Online resource; title from PDF title page (ScienceDirect, viewed November 18, 2015).
|
| 505 |
0 |
|
|a Title page; Table of Contents; Copyright; Contributors; Preface; Special Reviews in SEDA 37; Table of Essays, Annuals 1-36; Abbreviations; ADRs, ADEs and SEDs: A Bird's Eye View; I Introduction; References on Adverse Drug Reactions; II Pharmacogenomics Considerations; References Pharmacogenomics Considerations; III Immunological Reactions; References; IV Analysis of Toxicological Reactions; References; V Grades of Adverse Drug Reactions; References; VI FDA Pregnancy Categories/Classification of teratogenicity; References; Conclusion.
|
| 505 |
8 |
|
|a Chapter 1: Central Nervous System Stimulants and Drugs That Suppress AppetiteAbstract; Methylxanthines; Vigilance Promoting Drugs; Parasympathomimetics [SEDA-32, 19; SEDA-33, 15; SEDA-34, 9]; Chapter 2: Antidepressants; Abstract; General; Selective Serotonin Re-Uptake Inhibitors (SSRIs) [SED-15, 3109; SEDA-31, 18; SEDA-32, 33; SEDA-33, 26; SEDA-34, 17; SEDA-35, 30; SEDA-36, 14]; Serotonin and Noradrenaline Re-Uptake Inhibitors (SNRIs); Other Antidepressants; Chapter 3: Lithium; Abstract; Introduction; Organs and Systems; Second-Generation Effects; Susceptibility Factors; Interactions.
|
| 505 |
8 |
|
|a Diagnosis of Adverse Drug ReactionsManagement of Adverse Drug Reactions; Pharmacogenomics; Chapter 4: Drugs of Abuse; Abstract; Introduction; Cannabinoid; Alcohol; Benzodiazepines; Sympathomimetics-Cocaine; Opioids-Heroin; Electronic Cigarettes (E-Cigarettes); Conclusion; Chapter 5: Hypnosedatives and Anxiolytics; Abstract; Benzodiazepines; Hypnosedatives and Benzodiazepine-Like Drugs; Chapter 6: Antipsychotic Drugs; Abstract; General [SEDA-15, 2438; SEDA-32, 83; SEDA-33, 89; SEDA-34, 51; SEDA-35, 85; SEDA-36, 59]; Individual Drugs; Acknowledgements; Chapter 7: Antiepileptics; Abstract.
|
| 505 |
8 |
|
|a Chapter 8: Opioid Analgesics and Narcotic AntagonistsAbstract; Opioid Receptor Agonists; Alfentanil [SED-15, 72; SEDA-34, 152; SEDA-35, 173; SEDA-36, 108]; Codeine [SED-15, 880; SEDA -34, 152; SEDA-35, 174; SEDA-36, 108]; Dextrometrophan [SED-15, 1088; SEDA-34, 153; SEDA-35, 174; SEDA-36, 108]; Diamorphine [SED-15, 1096; SEDA-34, 153; SEDA-35, 175; SEDA-36, 108]; Dihydrocodeine [SED-15, 1125; SEDA-34, 154; SEDA-35, 175; SEDA-36, 108]; Fentanyl [SED-15, 1346; SEDA-34, 154; SEDA-35, 176; SEDA-36, 109]; Hydrocodone [SED-15, 1702; SEDA-34, 156; SEDA-35, 177; SEDA-36, 109]
|
| 505 |
8 |
|
|a Methadone [SED-15, 2270 SEDA-34, 157; SEDA-35, 177; SEDA-36, 110]; Morphine [SED-15, 2386; SEDA-34, 159; SEDA-35, 181; SEDA-36, 111]; Oxycodone [SED-15, 2651; SEDA-34, 161; SEDA-35, 182; SEDA-36, 111]; Papaverine [SED-15, 2678; SEDA-34, 162; SEDA-35, 183; SEDA-36, 112]; Pethidine (Meperidine) [SED-15, 2791; SEDA-34, 163; SEDA-35, 183; SEDA-36, 112]; Remifentanyl [SED-15, 3030; SEDA-34, 163; SEDA-35, 184; SEDA-36, 112]; Tramadol [SED-15, 3469; SEDA-34, 165; SEDA-35, 184; SEDA-36, 112]; Partial Opioid Receptor Agonists; Opioid Receptor Antagonists; Naloxone [SED-15, 2421.
|
| 520 |
|
|
|a Side Effects of Drugs Annual: A Worldwide Yearly Survey of New Data in Adverse Drug Reactions, Volume 40, first published in 1977, and continually published as a yearly update to the voluminous encyclopedia Meyler's Side Effects of Drugs, presents clinicians and medical investigators with a reliable and critical survey of new data and trends in the area of adverse drug reactions and interactions, with an international team of specialists contributing each year. Topics covered in this release include Central Nervous System Stimulants and Drugs that Suppress Appetite, Antidepressant drugs, Lithium, Drugs of abuse, Hypnotics and sedatives, Antipsychotic Drugs, and much more.
|
| 650 |
|
0 |
|a Drugs
|x Side effects.
|0 http://id.loc.gov/authorities/subjects/sh85039746
|
| 650 |
|
2 |
|a Drug-Related Side Effects and Adverse Reactions
|0 https://id.nlm.nih.gov/mesh/D064420
|
| 650 |
|
6 |
|a Médicaments
|x Effets secondaires.
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Drugs
|x Side effects.
|2 fast
|0 (OCoLC)fst00898912
|
| 700 |
1 |
|
|a Ray, Sidhartha D.,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|z 0444635254
|z 9780444635259
|w (OCoLC)919479584
|
| 856 |
4 |
0 |
|u https://www.sciencedirect.com/science/bookseries/03786080/37
|y Elsevier
|
| 903 |
|
|
|a HeVa
|
| 929 |
|
|
|a oclccm
|
| 999 |
f |
f |
|s 99b05c44-af48-5c79-87e7-7b7f483fbbfd
|i 5756ae93-9055-5aba-92c4-ce21a78157ce
|
| 928 |
|
|
|t Library of Congress classification
|a RM302.5
|l Online
|c UC-FullText
|u https://www.sciencedirect.com/science/bookseries/03786080/37
|z Elsevier
|g ebooks
|i 11878301
|
